141 related articles for article (PubMed ID: 16273004)
1. [Second-line treatment of advanced non-small-cell lung cancer: role of pemetrexed].
Pérol M
Rev Pneumol Clin; 2005 Sep; 61(4 Pt 2):4S14-7. PubMed ID: 16273004
[No Abstract] [Full Text] [Related]
2. Pemetrexed and maintenance therapy for non-small cell lung cancer.
Prescrire Int; 2011 Feb; 20(113):39. PubMed ID: 21488588
[No Abstract] [Full Text] [Related]
3. Pemetrexed in advanced non-small-cell lung cancer.
Fuld AD; Dragnev KH; Rigas JR
Expert Opin Pharmacother; 2010 Jun; 11(8):1387-402. PubMed ID: 20446853
[TBL] [Abstract][Full Text] [Related]
4. [Update of pemetrexed in thoracic oncology].
Brechot JM; Morère JF
Bull Cancer; 2007; 94 Spec No Actualites():S139-41. PubMed ID: 17845984
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and toxicity of pemetrexed as a third-line treatment for non-small cell lung cancer.
Sun JM; Lee KW; Kim JH; Kim YJ; Yoon HI; Lee JH; Lee CT; Lee JS
Jpn J Clin Oncol; 2009 Jan; 39(1):27-32. PubMed ID: 18952704
[TBL] [Abstract][Full Text] [Related]
6. Pemetrexed single agent in previously treated non-small cell lung cancer: a multi-institutional observational study.
Bearz A; Garassino I; Cavina R; Favaretto A; Boccalon M; Talamini R; Berretta M; Spazzapan S; Simonelli C; Santoro A; Tirelli U
Lung Cancer; 2008 May; 60(2):240-5. PubMed ID: 18022729
[TBL] [Abstract][Full Text] [Related]
7. Pemetrexed for the treatment of non-small-cell lung cancer.
Manegold C; Schmid-Bindert G; Pilz LR
Expert Rev Anticancer Ther; 2009 Sep; 9(9):1195-209. PubMed ID: 19761423
[TBL] [Abstract][Full Text] [Related]
8. The role of pemetrexed as maintenance treatment in advanced NSCLC: a Phase III randomized trial.
Gridelli C; Di Maio M
Expert Opin Pharmacother; 2010 Feb; 11(2):321-4. PubMed ID: 20053140
[TBL] [Abstract][Full Text] [Related]
9. Pemetrexed: new indication. Untreated non-small cell lung cancer: just another cytotoxic drug. No better than the gemcitabine-cisplatin combination with a different safety profile, as is the case for other cytotoxic drugs.
Prescrire Int; 2009 Jun; 18(101):114. PubMed ID: 19637425
[No Abstract] [Full Text] [Related]
10. [Study of use of pemetrexed in non-small cell lung cancer].
Villanueva-Herraiz S; Ortega-García MP; Camps-Herrero C; Blasco-Segura P
Farm Hosp; 2010; 34(4):194-203. PubMed ID: 20594885
[TBL] [Abstract][Full Text] [Related]
11. Role of pemetrexed in non-small cell lung cancer.
Longo-Sorbello GS; Chen B; Budak-Alpdogan T; Bertino JR
Cancer Invest; 2007 Feb; 25(1):59-66. PubMed ID: 17364559
[TBL] [Abstract][Full Text] [Related]
12. [Role of pemetrexed given with radiotherapy].
Mornex F
Rev Pneumol Clin; 2005 Sep; 61(4 Pt 2):4S18-9. PubMed ID: 16273005
[No Abstract] [Full Text] [Related]
13. [Pemetrexed: from preclinic to clinic].
Lansiaux A; Lokiec F
Bull Cancer; 2007; 94 Spec No Actualites():S134-8. PubMed ID: 17845983
[TBL] [Abstract][Full Text] [Related]
14. Pemetrexed in the treatment of thoracic malignancies: a single centre experience in Singapore.
Lopes G; Chopra A; Kukutschka J; Portillo P; Bharwani L; Chang A
Singapore Med J; 2011 Mar; 52(3):190-4. PubMed ID: 21451928
[TBL] [Abstract][Full Text] [Related]
15. Updated clinical information on multitargeted antifolates in lung cancer.
Scagliotti GV; Ceppi P; Capelletto E; Novello S
Clin Lung Cancer; 2009 Mar; 10 Suppl 1():S35-40. PubMed ID: 19362945
[TBL] [Abstract][Full Text] [Related]
16. Pemetrexed in first-line treatment of non-small cell lung cancer.
Esteban E; Casillas M; Cassinello A
Cancer Treat Rev; 2009 Jun; 35(4):364-73. PubMed ID: 19269106
[TBL] [Abstract][Full Text] [Related]
17. Review of a promising new agent--pemetrexed disodium.
Paz-Ares L; Bezares S; Tabernero JM; Castellanos D; Cortes-Funes H
Cancer; 2003 Apr; 97(8 Suppl):2056-63. PubMed ID: 12673697
[TBL] [Abstract][Full Text] [Related]
18. [Safety of pemetrexed mono-therapy in elderly patients with non-small cell lung cancer].
Konishi A; Kitada N; Nanjo S; Tanaka S; Tomii K; Katakami N; Hashida T
Gan To Kagaku Ryoho; 2012 Oct; 39(10):1507-10. PubMed ID: 23064061
[TBL] [Abstract][Full Text] [Related]
19. Pemetrexed: a multitargeted antifolate.
Rollins KD; Lindley C
Clin Ther; 2005 Sep; 27(9):1343-82. PubMed ID: 16291410
[TBL] [Abstract][Full Text] [Related]
20. [Pemetrexed development in oncology].
Chaigneau L; Villanueva C; Thierry-Vuillemin A; Legat-Fagnoni C; N'Guyen T; Maurina T; Lorgis V; Pivot X
Bull Cancer; 2007; 94 Spec No Actualites():S142-8. PubMed ID: 17845985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
